Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

por Moore, David F, Altarescu, Gheona, Herscovitch, Peter, Schiffmann, Raphael
Publicado 2002

Increased Signal Intensity in the Pulvinar on T1-Weighted Images: A Pathognomonic MR Imaging Sign of Fabry Disease

por Moore, David F., Ye, Frank, Schiffmann, Raphael, Butman, John A.
Publicado en AJNR Am J Neuroradiol (2003)

Clinical Use of Diffusion-Tensor Imaging for Diseases Causing Neuronal and Axonal Damage

por Uluğ, Aziz M., Moore, David F., Bojko, Aviva S., Zimmerman, Robert D.
Publicado en AJNR Am J Neuroradiol (1999)

Hepatitis C and recurrent treatment-resistant acute ischemic stroke

por Saxsena, Aneeta, Tarsia, Joseph, Dunn, Casey, Aysenne, Aimee, Shah, Basil, Moore, David F.
Publicado 2013

Arterial Wall Properties and Womersley Flow in Fabry Disease

por Moore, David F, Altarescu, Gheona, Pursley, Randall, Campia, Umberto, Panza, Julio A, Dimitriadis, Emilios, Schiffmann, Raphael
Publicado 2002

An animal-to-human scaling law for blast-induced traumatic brain injury risk assessment

por Jean, Aurélie, Nyein, Michelle K., Zheng, James Q., Moore, David F., Joannopoulos, John D., Radovitzky, Raúl
Publicado 2014

Enhanced Endothelium-Dependent Vasodilation in Fabry Disease

por Altarescu, Gheona, Moore, David F., Pursley, Randall, Campia, Umberto, Goldstein, Seth, Bryant, Melissa, Panza, Julio A., Schiffmann, Raphael
Publicado en Stroke (2001)

Reply to Moss et al.: Military and medically relevant models of blast-induced traumatic brain injury vs. ellipsoidal heads and helmets

por Nyein, Michelle K., Jason, Amanda M., Yu, Li, Pita, Claudio M., Joannopoulos, John D., Moore, David F., Radovitzky, Raul
Publicado 2011

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells

por Shen, Jin-Song, Meng, Xing-Li, Moore, David F., Quirk, Jane M., Shayman, James A., Schiffmann, Raphael, Kaneski, Christine R.
Publicado 2008

In silico investigation of intracranial blast mitigation with relevance to military traumatic brain injury

por Nyein, Michelle K., Jason, Amanda M., Yu, Li, Pita, Claudio M., Joannopoulos, John D., Moore, David F., Radovitzky, Raul A.
Publicado 2010

Skin-impedance in Fabry Disease: A prospective, controlled, non-randomized clinical study

por Gupta, Surya N, Ries, Markus, Murray, Gary J, Quirk, Jane M, Brady, Roscoe O, Lidicker, Jeffrey R, Schiffmann, Raphael, Moore, David F
Publicado 2008

Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalities

por Moore, David F., Krokhin, Oleg V., Beavis, Ronald C., Ries, Markus, Robinson, Chevalia, Goldin, Ehud, Brady, Roscoe O., Wilkins, John A., Schiffmann, Raphael
Publicado 2007

Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach

por Moore, David F., Gelderman, Monique P., Ferreira, Paulo A., Fuhrmann, Steven R., Yi, Haiqing, Elkahloun, Abdel, Lix, Lisa M., Brady, Roscoe O., Schiffmann, Raphael, Goldin, Ehud
Publicado 2007

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy?

por Kateb, Babak, Chiu, Katherine, Black, Keith L., Yamamoto, Vicky, Khalsa, Bhavraj, Ljubimova, Julia Y., Ding, Hui, Patil, Rameshwar, Portilla-Arias, Jose Antonio, Modo, Mike, Moore, David F., Farahani, Keyvan, Okun, Michael S., Prakash, Neal, Neman, Josh, Ahdoot, Daniel, Grundfest, Warren, Nikzad, Shouleh, Heiss, John D.
Publicado 2010